跳至主要内容
临床试验/IRCT20200502047276N1
IRCT20200502047276N1尚未招募1 期

The neuroprotective effect of memantine during cardiopulmonary bypass in patients that are candidate for cardiac surgery

Mazandaran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients that are candidate for open heart surgery
  • Age between 18 to 80 years

排除标准

  • Acute or chronic renal failure (AKI stage 4 or 5)
  • Creatinine clearance less than 30 ml/min
  • Moderate to severe hepatic failure
  • Autoimmune disease
  • Alzheimer or dementia
  • History of memantine consumption within last 6 months
  • History of seizure, CVA, or psychiatric disorders

研究者

相似试验